HUK 122 LIMITED
Company number 14459259 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
HUK 122 LIMITED - Analysis Report
Company Number: 14459259
Analysis Date: 2025-07-20 19:29 UTC
Financial Health Assessment of HUK 122 LIMITED
1. Financial Health Score: A-
Explanation:
HUK 122 LIMITED exhibits strong early-stage financial health with solid net current assets, positive operating profitability, and robust shareholders’ equity relative to its size and age. The company is newly incorporated (Nov 2022) but has demonstrated a healthy cash flow pattern through significant receivables and a strong profit before tax. The minimal administrative expenses and positive audit opinion further support a favorable financial condition. The slight deduction in efficiency of cash conversion (very low cash on hand) warrants attention but is not currently a critical issue.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 797,653 | Indicates good short-term asset base, mostly tied up in debtors (accounts receivable). |
| Cash Balance | 183 | Extremely low cash on hand; potential liquidity risk if receivables are not collected timely. |
| Current Liabilities | 241,829 | Moderate liabilities due within one year; manageable given current assets. |
| Net Current Assets | 555,824 | Strong positive working capital; company can meet short-term obligations comfortably. |
| Net Assets / Equity | 555,824 | Positive equity reflects retained earnings and owner investment; good financial foundation. |
| Profit Before Tax | 726,540 | Indicates profitable operations for the period (61 weeks); excellent for a newly formed entity. |
| Tax Charge | 170,717 | Reasonable tax expense consistent with profit level. |
| Operating Profit | 316,535 | Indicates core business generates profit before financing costs. |
| Interest Expense | 6,121 | Minimal debt-related costs, suggesting low gearing or borrowing. |
| Audit Opinion | Unqualified | Independent auditor confirms accounts present true and fair view; no concerns over legality or accuracy. |
3. Diagnosis: Financial “Patient” Status
Healthy Cash Flow but Liquidity Warning: The company’s cash on hand is very low (£183), which is a symptom of potential liquidity distress if receivables are not converted to cash promptly. While net current assets are strong due to large debtors, cash is the immediate lifeblood for day-to-day operations.
Strong Profitability and Growth Potential: The company has delivered a substantial profit before tax (£726k) in its first financial period, indicating a strong business model and operational efficiency. This is a positive sign akin to a patient showing good vital signs after initial treatment.
Stable Capital Structure: Positive net assets and shareholders’ funds underscore a sound equity base. The minimal interest expense suggests low financial leverage, reducing risk from debt servicing burdens.
Newly Incorporated Stage: As a company formed in late 2022, the financials reflect a start-up phase with promising momentum but limited financial history. It is important to monitor continued profitability and cash flow over subsequent periods.
Governance and Controls: The presence of experienced directors and an unqualified auditor's report indicate effective governance and financial controls, reducing the risk of financial “infection.”
4. Recommendations: Treatment Plan for Financial Wellness
Improve Cash Management:
- Accelerate debtor collection procedures to convert receivables into cash faster.
- Consider short-term financing options or credit facilities to buffer against cash flow timing gaps.
Monitor Working Capital Regularly:
- Maintain close oversight on current assets and liabilities to ensure ongoing liquidity.
- Avoid over-reliance on receivables as working capital; diversify asset base if possible.
Sustain Profitability and Margin Control:
- Keep administrative expenses tightly controlled, as currently minimal, to preserve operating margins.
- Explore avenues to increase operating income and manage operating charges efficiently.
Strategic Growth Planning:
- Leverage current strong financial position to invest in business expansion or product/service development, ensuring growth does not outpace cash flow capacity.
Regular Financial Health Reviews:
- Conduct periodic financial health checks similar to this diagnostic to detect early warning signs of distress.
- Stay compliant with filing deadlines to avoid penalties and maintain stakeholder confidence.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.